Directed-evolution approach to empower EGFR targeting for immunotherapy

Area of Science:

• Biotechnology
• Molecular Biology
• Immunology

Background:

• Directed evolution technologies are advancing strategies for isolating specific binding proteins.
• Identifying proteins that recognize disease-associated protein states is crucial for therapeutic development.

Purpose of the Study:

• To devise a yeast display-based selection scheme.
• To discover proteins that specifically engage the cancer-associated activated state of a receptor.

Main Methods:

• Yeast display technology was employed for protein selection.
• A selection scheme was designed to isolate proteins binding to activated receptor states.

Main Results:

• The study successfully developed a method to discover proteins targeting specific protein conformations.
• The identified proteins bind to the activated state of a cancer-associated receptor.

Conclusions:

• This yeast display-based selection scheme enables the discovery of proteins targeting disease-associated protein states.
• The findings facilitate the design of safer and more effective immunotherapies by targeting specific receptor activation states.